Turnstone Biologics Corp.

TSBX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$71-$55-$31$33
Dep. & Amort.$2$3$4$1
Deferred Tax$0-$5$8$2
Stock-Based Comp.$4$4$6$3
Change in WC$0-$18-$58-$86
Other Non-Cash-$2$5-$0$1
Operating Cash Flow-$67-$66-$71-$46
Investing Activities
PP&E Inv.-$0-$1-$5-$3
Net Acquisitions$0$0$0$0
Inv. Purchases-$7-$110-$60-$41
Inv. Sales/Matur.$86$83$50$41
Other Inv. Act.$0$0$0$0
Investing Cash Flow$79-$28-$15-$3
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$78$0$80
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$1-$3$80
Financing Cash Flow$0$77-$3$80
Forex Effect$0$0$0$0
Net Chg. in Cash$11-$17-$89$31
Supplemental Information
Beg. Cash$18$35$124$93
End Cash$29$18$35$124
Free Cash Flow-$68-$67-$76-$49
Turnstone Biologics Corp. (TSBX) Financial Statements & Key Stats | AlphaPilot